Company Data
Astria Therapeutics Inc.
Ticker
ATXS
Current Price
$12.47 -2.65%
Market Cap
$711.8M
Price Target
Refer to Report
Volume
1.3M
52wk Range
$3.555 - $13.29
Overview
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema.